Last reviewed · How we verify
Carbocaine
Carbocaine is a Small molecule drug developed by Nantes University Hospital. It is currently FDA-approved for Administration of Local Anesthetic Nerve Block, Administration of Regional Anesthesia, Local anesthesia. Also known as: Loco regional Analgesia.
Carbocaine is a local anesthetic of the amide type, used for conditions such as symptomatic irreversible pulpitis, nerve block, and surgery. It is a small molecule with a reasonably rapid onset and medium duration of action.
At a glance
| Generic name | Carbocaine |
|---|---|
| Also known as | Loco regional Analgesia |
| Sponsor | Nantes University Hospital |
| Target | Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha |
| Modality | Small molecule |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
- Administration of Local Anesthetic Nerve Block
- Administration of Regional Anesthesia
- Local anesthesia
- Local anesthesia, by infiltration
Common side effects
- Respiratory arrest
- Convulsions
- Unconsciousness
- Drowsiness
- Cardiovascular catastrophe
- Seizure
- Progressive cerebral hypoxia
- Nervousness
- Dizziness
- Blurred vision
- Tremors
- Paresthesias of the lips
Key clinical trials
- Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension (PHASE4)
- Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy (NA)
- Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction (PHASE1, PHASE2)
- Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total Knee Arthroplasty (PHASE4)
- Oct Angiography Changes After Local Anesthesia in Cataract Surgery (NA)
- PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach (NA)
- A Randomized Controlled Trial Evaluating Whether Pre-operative Trinase Reduces Post-operative Pain in Patients With Symptomatic Irreversible Pulpitis Compared to Placebo, Using VAS Scores and Analgesic Intake Over 48 Hours. (NA)
- Platelet-Rich Plasma Versus Home-Based Exercise for Partial-Thickness Supraspinatus Tears (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carbocaine CI brief — competitive landscape report
- Carbocaine updates RSS · CI watch RSS
- Nantes University Hospital portfolio CI
Frequently asked questions about Carbocaine
What is Carbocaine?
What is Carbocaine used for?
Who makes Carbocaine?
Is Carbocaine also known as anything else?
What development phase is Carbocaine in?
What are the side effects of Carbocaine?
What does Carbocaine target?
Related
- Target: All drugs targeting Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha
- Manufacturer: Nantes University Hospital — full pipeline
- Therapeutic area: All drugs in Pain
- Indication: Drugs for Administration of Local Anesthetic Nerve Block
- Indication: Drugs for Administration of Regional Anesthesia
- Indication: Drugs for Local anesthesia
- Also known as: Loco regional Analgesia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing